Holen Sie sich die Stockscreener-App
0.00
100.00%
-2.72
Schlusskurs vom Vortag:
$2.72
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$9.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$4.6054
Cosciens Biopharma Inc Stock (CSCI) Company Profile
Firmenname
Cosciens Biopharma Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CSCI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSCI
Cosciens Biopharma Inc
|
0.00 | 9.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cosciens Biopharma Inc Aktie (CSCI) Neueste Nachrichten
(CSCI) Trading Advice (CSCI:CA) - news.stocktradersdaily.com
(CSCI) Technical Pivots with Risk Controls (CSCI:CA) - news.stocktradersdaily.com
MSN Money - MSN
(CSCI) Strategic Investment Guide (CSCI:CA) - news.stocktradersdaily.com
Long Term Trading Analysis for (CSCI) (CSCI:CA) - news.stocktradersdaily.com
Is COSCIENS Biopharma Inc. stock a safe haven assetQuarterly Portfolio Report & Daily Volume Surge Signals - Newser
Why analysts upgrade COSCIENS Biopharma Inc. stockEarnings Summary Report & Entry Point Confirmation Alerts - Newser
Cosciens Biopharma Brief: Announcing Exclusive Distribution Agreement With Wuzhou Drug International For Macrilen In Hainan-Guangdong-Hong Kong-Macao Greater Bay Area And Singapore - MarketScreener
COSCIENS Biopharma Secures Exclusive Distribution Deal for Macrilen® in Asia - TipRanks
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore - The Manila Times
COSCIENS (TSX: CSCI) gives Wuzhou Macrilen rights, ten-year term, €800,000 order - Stock Titan
How COSCIENS Biopharma Inc. stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
(CSCI) Strategic Equity Report (CSCI:CA) - news.stocktradersdaily.com
Tools to assess COSCIENS Biopharma Inc.’s risk profileAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Is COSCIENS Biopharma Inc. stock a safe investment in uncertain marketsWall Street Watch & Low Drawdown Investment Ideas - newser.com
Can COSCIENS Biopharma Inc. stock deliver surprise earnings beat2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Chart overlay techniques for tracking COSCIENS Biopharma Inc.Earnings Recap Summary & Smart Money Movement Alerts - newser.com
(CSCI) Dynamic Trading Report (CSCI:CA) - news.stocktradersdaily.com
COSCIENS Biopharma Appoints Peter H. Puccetti as Interim CEO - MarketScreener
COSCIENS Biopharma Names Puccetti Interim CEO After Biehn Resigns - 富途牛牛
How currency fluctuations impact COSCIENS Biopharma Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Will COSCIENS Biopharma Inc. stock see insider buyingExit Point & Weekly Watchlist for Hot Stocks - newser.com
COSCIENS Biopharma appoints interim CEO - MSN
COSCIENS Biopharma Appoints New Interim CEO Amid Strategic Shifts - The Globe and Mail
COSCIENS Biopharma Inc. Announces Leadership Change - Lelezard
Cosciens Biopharma announces leadership change - MarketScreener
Live market analysis of COSCIENS Biopharma Inc.Dividend Hike & Growth Oriented Trading Recommendations - newser.com
COSCIENS Biopharma (TSX: CSCI) appoints Peter Puccetti interim CEO, succeeding Anna Biehn - Stock Titan
Finanzdaten der Cosciens Biopharma Inc-Aktie (CSCI)
Es liegen keine Finanzdaten für Cosciens Biopharma Inc (CSCI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):